Balchem/BCPC

$149.63

-1.57%
-
1D1W1MYTD1YMAX

About Balchem

Balchem Corporation develops, manufactures, distributes and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition and industrial markets. The Company's segments include Human Nutrition and Health (HNH), Animal Nutrition and Health (ANH), and Specialty Products. The HNH segment provides human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. This segment also manufactures specialty vitamin K2, which plays a role in the human body for bone health, heart health and immunity, and methylsulfonylmethane (MSM). ANH segment provides nutritional products derived from its microencapsulation and chelation technologies in addition to the nutrient choline chloride. Through Specialty Products, it re-packages and distributes a number of gases and chemicals for various uses by its customers, notably ethylene oxide, propylene oxide, and ammonia.

Ticker

BCPC

Sector

Basic Materials

Trading on

NASDAQ

Industry

Chemical Manufacturing

CEO

Theodore Harris

Employees

1,301

Headquarters

Montvale, United States

Balchem Metrics

BasicAdvanced
$5B
Market cap
43.32
P/E ratio
$3.53
EPS
0.70
Beta
$0.79
Dividend rate
0.52%
Dividend yield
$5B
0.69572
$159.52
$110.74
94K
$0.79
2.611
1.724
28.13
28.154
24.59%
47.692
7.1%
7.14%
11.19%
7.71%
43.315
5.337
4.599
39.625
40.778
0.49%
0.52%
0.52%
-1.74%
15.33%
9.44%
8.71%
10.85%

What the Analysts think about Balchem

Analyst Ratings

Majority rating from 2 analysts.
Buy

Price Targets

Average projection from 3 analysts.
10.94% upside
High $170.00
Low $163.00
$149.63
Current price
$166.00
Average price target

Balchem Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
12.06% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$240M
4.81%
Net income
$29M
8.65%
Profit margin
12.06%
3.7%

Balchem Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 5.1%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
$1.06
$1.04
$0.95
$1.03
-
Expected
$0.84
$0.97
$0.93
$0.98
$1.02
Surprise
26.19%
7.22%
2.15%
5.1%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

FAQs

What’s the current market cap for Balchem stock?

Balchem (BCPC) has a market cap of $5B as of May 29, 2024.

What is the P/E ratio for Balchem stock?

The price to earnings (P/E) ratio for Balchem (BCPC) stock is 43.32 as of May 29, 2024.

Does Balchem stock pay dividends?

Yes, the Balchem (BCPC) stock pays dividends to shareholders. As of May 29, 2024, the dividend rate is $0.79 and the yield is 0.52%. Balchem has a payout ratio of 24.59% on a trailing twelve-month basis.

When is the next Balchem dividend payment date?

The next Balchem (BCPC) dividend payment date is unconfirmed.

What is the beta indicator for Balchem?

Balchem (BCPC) has a beta rating of 0.7. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.

What is the Balchem stock price target?

The target price for Balchem (BCPC) stock is $166, which is 10.94% above the current price of $149.63. This is an average based on projections from 3 analysts, and represents their view of what the stock price could be in 12 or 18 months. This should not be seen as investment advice - Lightyear does not carry out investment research.

Buy or sell Balchem stock

Buy or sell Balchem stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing